Arvee Laboratories (India): 7 Stock Signals Investors Are Watching Right Now

Arvee Laboratories (India) CMP Rs 158.01. 52W range Rs 126.54 to Rs 290.78. Mcap Rs 174 crore.

Arvee Laboratories (India) stock signals are unusually layered right now, with the company trading at Rs 158.01, the stock trades 45.6 percent below its 52 week high of Rs 290.78 and 24.9 percent above its 52 week low of Rs 126.54. Arvee Laboratories (India) is a well tracked name in the a specialty chemicals manufacturer based in Ahmedabad, making thiophene derivatives and related fine chemicals space, and no single headline captures where the stock stands today.

This article does not make a buy, hold or sell call on Arvee Laboratories (India). It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.

Click Here to Get Free Investment Predictions

Arvee Laboratories (India) Stock at a Glance

Before going through each of the seven Arvee Laboratories (India) stock signals in detail, the snapshot below sets the starting point on price, valuation and balance sheet strength.

1. Earnings Trend at Arvee Laboratories (India)

Annual revenue for Arvee Laboratories rose 26.33 percent to Rs 39.14 crore in FY2025 from Rs 30.99 crore in FY2024, while annual net profit more than doubled, rising 104.15 percent to Rs 2.15 crore from Rs 1.05 crore, a sharp recovery after a weaker FY2024.

This is the first of the seven Arvee Laboratories (India) stock signals worth tracking closely into the next results.

2. FII Holding in Arvee Laboratories (India)

A full quarterly FII holding series was not available from the data source used here for Arvee Laboratories (India). Where that is the case, the most reliable next step is to check the company’s latest exchange filing directly, since a single quarter snapshot can be misleading without the trend around it.

This is worth revisiting once the next quarterly shareholding disclosure is filed.

3. Promoter Holding in Arvee Laboratories (India)

Promoter holding in Arvee Laboratories (India) stood at 73.50 percent as of March 2026, one of the shareholding signals worth tracking alongside institutional flows.

This is worth revisiting once the next quarterly shareholding disclosure is filed, to see whether the level and direction of change persists.

4. Debt Position at Arvee Laboratories (India)

Arvee Laboratories’ promoter holding of 73.50 percent has stayed unchanged over recent quarters, a signal of continued promoter commitment even as the specialty chemicals business works through a period of revenue volatility.

This is one of the balance sheet signals worth tracking alongside the earnings trend from Signal 1, since capital raising plans can shift the picture from one quarter to the next.

5. Valuation of Arvee Laboratories (India) Shares

With EPS of Rs 2.29 and a P/B ratio of 5.15, the stock’s valuation reflects the market pricing in a continuation of the sharp FY2025 profit recovery.

Whether that valuation looks justified depends on the earnings trend from Signal 1 continuing, and it is one of the clearer places where the seven signals can pull in different directions at the same time.

6. Technical Trend on the Arvee Laboratories (India) Chart

The sixth of these Arvee Laboratories (India) stock signals is the price chart itself. The stock trades 45.6 percent below its 52 week high of Rs 290.78 and 24.9 percent above its 52 week low of Rs 126.54.

Over the past year the stock has moved between Rs 126.54 and Rs 290.78, a range worth watching for a break in either direction as the next signal on where sentiment is heading.

7. Corporate Developments at Arvee Laboratories (India)

The seventh and final of these Arvee Laboratories (India) stock signals is corporate activity. Arvee Laboratories, incorporated in 2012 in Ahmedabad and led by Managing Director Shalin Sudhakarbhai Patel, manufactures specialised chemicals through processes including nitration, sulfonation and the Hoffman reaction, and reported a sharp swing back to profit growth in its most recently disclosed annual results.

Check the Univest Screener for live fundamentals

What These Arvee Laboratories (India) Stock Signals Mean Together

None of these seven signals on its own settles the debate on Arvee Laboratories (India). Reading them as a set, rather than picking out any single one, is the more balanced way to approach the stock right now. The earnings trend, shareholding pattern, balance sheet position, valuation, technical setup and corporate developments each add one piece of the picture, and they do not all point the same way at the same time.

Investors weighing Arvee Laboratories (India) would do well to watch the next quarterly results for a read on where margins and profit are heading, alongside the next shareholding pattern update for any shift in institutional positioning. Reading these Arvee Laboratories (India) stock signals together, rather than in isolation, remains the more balanced approach. As with any single stock, price movements can be volatile and past trends do not guarantee future performance.

Conclusion

Arvee Laboratories (India) currently sits at the intersection of several moving parts, from earnings and shareholding to valuation and chart trend, and that is exactly what the seven signals above are meant to surface. This article does not recommend buying, holding or selling Arvee Laboratories (India) shares, and readers should form their own view based on their own research and risk appetite.

Download the Univest iOS App or Univest Android App to track Arvee Laboratories (India) live price and more such signal based stock research.

FAQs on Arvee Laboratories (India) Stock Signals

Why is Arvee Laboratories (India) share price where it is right now?

Ans. Arvee Laboratories (India) shares are trading The stock trades 45.6 percent below its 52 week high of Rs 290.78 and 24.9 percent above its 52 week low of Rs 126.54 shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.

What is Arvee Laboratories (India)’s current FII holding?

Ans. A full quarterly FII holding series was not available for this article; check the company’s latest exchange filing directly.

Is Arvee Laboratories (India)’s debt position a concern right now?

Ans. Arvee Laboratories’ promoter holding of 73.50 percent has stayed unchanged over recent quarters, a signal of continued promoter commitment even as the specialty chemicals business works through a period of revenue volatility.

What is the promoter holding in Arvee Laboratories (India)?

Ans. Promoter holding in Arvee Laboratories (India) stood at 73.50 percent as of March 2026.

Is Arvee Laboratories (India) expensive compared to its sector?

Ans. With EPS of Rs 2.29 and a P/B ratio of 5.15, the stock’s valuation reflects the market pricing in a continuation of the sharp FY2025 profit recovery.

What recent corporate developments are relevant to Arvee Laboratories (India)?

Ans. Arvee Laboratories, incorporated in 2012 in Ahmedabad and led by Managing Director Shalin Sudhakarbhai Patel, manufactures specialised chemicals through processes including nitration, sulfonation and the Hoffman reaction, and reported a sharp swing back to profit growth in its most recently disclosed annual results.

What do the technical charts suggest about Arvee Laboratories (India) right now?

Ans. The stock trades 45.6 percent below its 52 week high of Rs 290.78 and 24.9 percent above its 52 week low of Rs 126.54.

Should investors buy Arvee Laboratories (India) shares at current levels?

Ans. This article does not offer a buy, hold or sell recommendation. It lays out seven Arvee Laboratories (India) stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.